|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8740 EUR | +1.86% |
|
-2.35% | -43.10% |
| Jun. 18 | AB Science Secures US Patent for Prostate Cancer Therapy | MT |
| Jun. 18 | AB Science Secures New U.S. Patent for Masitinib |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AB SCIENCE | Specialty & Advanced Pharmaceuticals | +1.86% | -2.35% | -43.10% | -37.75% | -89.22% | 76.29M |  | | |
- Stock Market
- Stocks
- AB Stock
- Charts AB Science
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
